Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Income towards Parent Company (2016 - 2017)

Historic Income towards Parent Company for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$2.8 million.

  • Bone Biologics' Income towards Parent Company rose 4105.06% to -$2.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$7.1 million, marking a year-over-year increase of 7275.14%. This contributed to the annual value of -$1.6 million for FY2021, which is 1172.83% up from last year.
  • Latest data reveals that Bone Biologics reported Income towards Parent Company of -$2.8 million as of Q4 2017, which was up 4105.06% from -$2.4 million recorded in Q3 2017.
  • Over the past 5 years, Bone Biologics' Income towards Parent Company peaked at $1.0 million during Q2 2017, and registered a low of -$12.3 million during Q1 2016.